Inicio › Cáncer de próstata › Minnesota › Minneapolis
Ensayos clínicos de Cáncer de próstata en Minneapolis, MN
22 estudios para Cáncer de próstata buscan participantes en centros de Minneapolis y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
ReclutandoFase 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- y 1 más
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
ReclutandoFase 2
- Hennepin County Medical Center, Minneapolis
The Vanguard Study: Testing a New Way to Screen for Cancer
ReclutandoSe aceptan voluntarios sanos
- Minneapolis VA Medical Center, Minneapolis
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · A 5 mi de distancia
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
ReclutandoFase 1
- University Of Minnesota, Minneapolis
Evaluating Prostate Cancer Patient Natural Killer Cell Function Across Racial Background and Addressing Functional Disparities With Trispecific Killer Engagers
ReclutandoEstudio observacional
- University of Minnesota/Masonic Cancer Center, Minneapolis
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
ReclutandoFase 3
- HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0032), Saint Louis Park · A 5 mi de distancia
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
ReclutandoFase 1
- University of Minnesota Medical Center, Minneapolis
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 2
- Health Partners Frauenshuh Cancer Center, Saint Louis Park · A 5 mi de distancia
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
ReclutandoFase 3
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · A 5 mi de distancia
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
ReclutandoFase 3
- HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0072), Saint Louis Park · A 5 mi de distancia
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
ReclutandoFase 3
- Minnesota Oncology Hematology PA, Minneapolis
- University of Minnesota Medical Center Fairview, Minneapolis
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
ReclutandoFase 1/2
- Research Site, Minneapolis
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
ReclutandoFase 3
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · A 5 mi de distancia
FOG-001 in Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
ReclutandoFase 1
- M Health Fairview Clinics and Surgery Center, Minneapolis
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
ReclutandoFase 2
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
ReclutandoFase 2
- Masonic Cancer Center, Minneapolis
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
ReclutandoFase 1
- Minnesota Oncology Hematology, Minneapolis
Axelopran for Advanced Cancer in Patients Receiving Opioids
ReclutandoFase 2
- HealthPartners Frauenshuh Cancer Research Center, Saint Louis Park · A 5 mi de distancia
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
ReclutandoFase 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- y 1 más
Vitamin D for Prostate Endocrine Therapy
ReclutandoFase 3
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · A 5 mi de distancia
Más información sobre Cáncer de próstata en MedlinePlus
Ensayos de Cáncer de próstata en otras ciudades
- New York City, NY101 estudios
- Houston, TX73 estudios
- Los Angeles, CA64 estudios
- Boston, MA56 estudios
- Seattle, WA45 estudios
- St. Louis, MO45 estudios
- Chicago, IL45 estudios
- Baltimore, MD45 estudios
- San Francisco, CA44 estudios
- Philadelphia, PA41 estudios
- Nashville, TN40 estudios
- Washington, DC39 estudios
Otros estudios en Minneapolis
- Cáncer de pulmón de células no pequeñas29 estudios
- Cáncer de seno23 estudios
- Cáncer de ovario23 estudios
- Fallo cardíaco22 estudios
- Cáncer (todos los tipos)21 estudios
- Cáncer de endometrio20 estudios
- Cáncer del colon y del recto20 estudios
- Cáncer de pulmón20 estudios
- Leucemia mielógena aguda19 estudios
- Enfermedad de Parkinson17 estudios
- Enfermedad de las arterias coronarias15 estudios
- Enfermedad cardiovascular15 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.